zip >>> 02210
sector >>> Healthcare
fullTimeEmployees >>> 3082
longBusinessSummary >>> Alexion Pharmaceuticals, Inc. develops and commercializes various therapeutic products. The company offers ULTOMIRIS (ALXN1210/ravulizumab-cwvz), a C5 inhibitor for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS); and SOLIRIS (eculizumab), a monoclonal antibody for the treatment of PNH, aHUS, generalized myasthenia gravis (gMG), and neuromyelitis optica spectrum disorder (NMOSD). It also provides Strensiq (asfotase alfa), a targeted enzyme replacement therapy for patients with hypophosphatasia; and Kanuma (sebelipase alfa) for the treatment of patients with lysosomal acid lipase deficiency. In addition, the company is developing ALXN1210 (Intravenous) that is in Phase III clinical trials for the treatment of gMG and NMOSD; ALXN1210 (Subcutaneous), which is in Phase III clinical trials for PNH and aHUS; ALXN1810 (Subcutaneous) that is in Phase I clinical trial for renal diseases; and ALXN1720 (Subcutaneous), which is in Phase I clinical trial for the treatment of disease states involving dysregulated terminal complement activity. Further, it is developing ALXN1840 (WTX101) that is in Phase III clinical trials for the treatment of Wilson disease; and ALXN1830 and ABY-039, which are in Phase I clinical trials for neonatal Fc receptor. The company serves distributors, pharmacies, hospitals, hospital buying groups, and other healthcare providers in the United States and internationally. Alexion Pharmaceuticals, Inc. has collaboration and license agreement with Halozyme Therapeutics, Inc.; collaborations with Caelum Biosciences, Inc., Dicerna Pharmaceuticals, Inc. and Zealand Pharma A/S; strategic agreement with Caelum Biosciences, Inc.; agreement with Stealth BioTherapeutics Corp.; and a partnership with Affibody AB. The company was founded in 1992 and is headquartered in Boston, Massachusetts.
city >>> Boston
phone >>> 475 230 2596
state >>> MA
country >>> United States
companyOfficers >>> []
website >>> http://www.alexion.com
maxAge >>> 1
address1 >>> 121 Seaport Boulevard
fax >>> 203 271 8198
industry >>> Biotechnology
previousClose >>> 158.71
regularMarketOpen >>> 159.1
twoHundredDayAverage >>> 121.38234
trailingAnnualDividendYield >>> None
payoutRatio >>> 0
volume24Hr >>> None
regularMarketDayHigh >>> 158.97
navPrice >>> None
averageDailyVolume10Day >>> 3315716
totalAssets >>> None
regularMarketPreviousClose >>> 158.71
fiftyDayAverage >>> 146.40454
trailingAnnualDividendRate >>> None
open >>> 159.1
toCurrency >>> None
averageVolume10days >>> 3315716
expireDate >>> None
yield >>> None
algorithm >>> None
dividendRate >>> None
exDividendDate >>> None
beta >>> 1.336134
circulatingSupply >>> None
startDate >>> None
regularMarketDayLow >>> 157.26
priceHint >>> 2
currency >>> USD
trailingPE >>> 36.6071
regularMarketVolume >>> 3546536
lastMarket >>> None
maxSupply >>> None
openInterest >>> None
marketCap >>> 34501050368
volumeAllCurrencies >>> None
strikePrice >>> None
averageVolume >>> 2491025
priceToSalesTrailing12Months >>> 5.885141
dayLow >>> 157.26
ask >>> 158.36
ytdReturn >>> None
askSize >>> 900
volume >>> 3546536
fiftyTwoWeekHigh >>> 160.03
forwardPE >>> 12.180696
fromCurrency >>> None
fiveYearAvgDividendYield >>> None
fiftyTwoWeekLow >>> 72.67
bid >>> 155.5
tradeable >>> False
dividendYield >>> None
bidSize >>> 800
dayHigh >>> 158.97
exchange >>> NMS
shortName >>> Alexion Pharmaceuticals, Inc.
longName >>> Alexion Pharmaceuticals, Inc.
exchangeTimezoneName >>> America/New_York
exchangeTimezoneShortName >>> EST
isEsgPopulated >>> False
gmtOffSetMilliseconds >>> -18000000
quoteType >>> EQUITY
symbol >>> ALXN
messageBoardId >>> finmb_347983
market >>> us_market
annualHoldingsTurnover >>> None
enterpriseToRevenue >>> 6.04
beta3Year >>> None
profitMargins >>> 0.16317
enterpriseToEbitda >>> 11.405
52WeekChange >>> 0.42468584
morningStarRiskRating >>> None
forwardEps >>> 12.95
revenueQuarterlyGrowth >>> None
sharesOutstanding >>> 218720992
fundInceptionDate >>> None
annualReportExpenseRatio >>> None
bookValue >>> 50.57
sharesShort >>> 3677476
sharesPercentSharesOut >>> 0.0168
fundFamily >>> None
lastFiscalYearEnd >>> 1577750400
heldPercentInstitutions >>> 0.93362
netIncomeToCommon >>> 956600000
trailingEps >>> 4.309
lastDividendValue >>> None
SandP52WeekChange >>> 0.1436472
priceToBook >>> 3.1192408
heldPercentInsiders >>> 0.0027700001
nextFiscalYearEnd >>> 1640908800
mostRecentQuarter >>> 1601424000
shortRatio >>> 1.04
sharesShortPreviousMonthDate >>> 1606694400
floatShares >>> 218059777
enterpriseValue >>> 35406659584
threeYearAverageReturn >>> None
lastSplitDate >>> 1306108800
lastSplitFactor >>> 2:1
legalType >>> None
lastDividendDate >>> None
morningStarOverallRating >>> None
earningsQuarterlyGrowth >>> 0.236
dateShortInterest >>> 1609372800
pegRatio >>> 1.19
lastCapGain >>> None
shortPercentOfFloat >>> 0.0175
sharesShortPriorMonth >>> 4257032
impliedSharesOutstanding >>> None
category >>> None
fiveYearAverageReturn >>> None
regularMarketPrice >>> 159.1
logo_url >>> https://logo.clearbit.com/alexion.com
